FDA Warns in AbbVie’s Hepatitis C Treatments for Patients with Liver Disease

The US Food and Drug Administration (FDA) has issued warnings on AbbVie’s new hepatitis C treatment drugs – Viekira Pak and Tec...

Oct 23 2015, 4:58am CDT

Follow Us
Follow I4U News on Twitter
Follow I4U News on Facebook